OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Production and characterization of mono-PEGylated alpha-1 antitrypsin for augmentation therapy
Xiao Liu, Kévin Vanvarenberg, Kobenan Guy Wilfried Kouassi, et al.
International Journal of Pharmaceutics (2021) Vol. 612, pp. 121355-121355
Closed Access | Times Cited: 6
Xiao Liu, Kévin Vanvarenberg, Kobenan Guy Wilfried Kouassi, et al.
International Journal of Pharmaceutics (2021) Vol. 612, pp. 121355-121355
Closed Access | Times Cited: 6
Showing 6 citing articles:
Impact of administration route and PEGylation on alpha-1 antitrypsin augmentation therapy
Xiao Liu, Bernard Učakar, Kévin Vanvarenberg, et al.
Journal of Controlled Release (2025), pp. 113643-113643
Closed Access
Xiao Liu, Bernard Učakar, Kévin Vanvarenberg, et al.
Journal of Controlled Release (2025), pp. 113643-113643
Closed Access
Nebulization of PEGylated recombinant human deoxyribonuclease I using vibrating membrane nebulizers: A technical feasibility study
Sohaib Mahri, Tobias Wilms, Paul Hagedorm, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 189, pp. 106522-106522
Open Access | Times Cited: 8
Sohaib Mahri, Tobias Wilms, Paul Hagedorm, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 189, pp. 106522-106522
Open Access | Times Cited: 8
Impact of the PEG length and PEGylation site on the structural, thermodynamic, thermal, and proteolytic stability of mono‐PEGylated alpha‐1 antitrypsin
Xiao Liu, Kobenan Guy Wilfried Kouassi, Rita Vanbever, et al.
Protein Science (2022) Vol. 31, Iss. 9
Open Access | Times Cited: 9
Xiao Liu, Kobenan Guy Wilfried Kouassi, Rita Vanbever, et al.
Protein Science (2022) Vol. 31, Iss. 9
Open Access | Times Cited: 9
Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin
Annalisa Bianchera, Viviana Vilardo, Roberta Giaccari, et al.
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 10, pp. 2653-2663
Open Access | Times Cited: 2
Annalisa Bianchera, Viviana Vilardo, Roberta Giaccari, et al.
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 10, pp. 2653-2663
Open Access | Times Cited: 2
Technoeconomic Analysis of Intensified PEGylated Biopharmaceutical Recombinant Protein Production: Alpha Antitrypsin as a Model Case
Salem Alkanaimsh, Abdullah M. Alsalal, Hesham El-Touney
Processes (2024) Vol. 12, Iss. 5, pp. 979-979
Open Access
Salem Alkanaimsh, Abdullah M. Alsalal, Hesham El-Touney
Processes (2024) Vol. 12, Iss. 5, pp. 979-979
Open Access
A breath of fresh air: inhaled antibodies to combat respiratory infectious diseases - a clinical trial overview
Noémie Alphonse, Thomas Sécher, Nathalie Heuzé-Vourc’h
Expert Opinion on Drug Delivery (2024)
Closed Access
Noémie Alphonse, Thomas Sécher, Nathalie Heuzé-Vourc’h
Expert Opinion on Drug Delivery (2024)
Closed Access
